The test showed that the release of mebeverine hydrochloride was slower than allowed by quality requirements, which affects the product’s effectiveness and poses a real and direct threat to patients’ health or life. Potential effects: lack of treatment efficacy, possible worsening of symptoms, complications.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use the product from batch EMBCD2064A. Patients should check the batch number of their medicine and, if it matches, return the product to the pharmacy or consult a doctor.
The distribution of Auroverin MR batch EMBCD2064A was suspended nationwide and the decision was given immediate enforceability after negative quality test results from the National Medicines Institute...
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related